Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Dupilumab |
Trade Name | |
Synonyms | REGN 668|REGN-668|REGN668|SAR 231893|SAR231893|SAR-231893 |
Drug Descriptions |
Dupilumab is a monoclonal antibody that targets IL-4Ralpha, resulting in decreased IL-4 and IL-13 signaling and potentially leading to decreased tumor cell survival (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | 1190264-60-8 |
NCIT ID | C162455 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cemiplimab + Dupilumab | Cemiplimab Dupilumab | 0 | 1 |
Dupilumab | Dupilumab | 0 | 1 |
Dupilumab + unspecified immune checkpoint inhibitor | Dupilumab unspecified immune checkpoint inhibitor | 0 | 0 |
Dupilumab + unspecified PD-L1 antibody | Dupilumab unspecified PD-L1 antibody | 0 | 0 |